SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.

Genes Chromosomes Cancer 2008 Mar;47(3):253-9

Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts, USA.

Germ line gain-of-function mutations in several members of the RAS/ERK pathway, including PTPN11, KRAS, and RAF1, cause the autosomal dominant genetic disorder Noonan Syndrome (NS). NS patients are at increased risk of leukemia/myeloproliferative disease and possibly some solid tumors, such as neuroblastoma. Recently, SOS1 gain of function mutations have also been shown to cause NS. Somatic PTPN11, KRAS, and RAF1 mutations occur (although at different frequencies) in a variety of sporadic neoplasms, but whether SOS1 mutations are associated with human cancer has not been evaluated. We sequenced DNA from a total of 810 primary malignancies, including pancreatic, lung, breast, and colon carcinomas, and acute myelogenous leukemia, as well as several neuroblastoma cell lines. From this large, diverse series, missense SOS1 mutations were identified in a single pancreatic tumor, one lung adenocarcinoma, and a T-cell acute lymphoblastic leukemia cell line. Our findings suggest that SOS1 is not a significant human oncogene in most cancers. Furthermore, NS patients with SOS1 mutations may not be at increased risk of developing cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20527DOI Listing
March 2008
51 Reads

Publication Analysis

Top Keywords

sos1 mutations
16
noonan syndrome
8
kras raf1
8
ptpn11 kras
8
increased risk
8
syndrome patients
8
sos1
6
mutations
6
mutations associated
4
sporadic neoplasms
4
associated human
4
neoplasms sos1
4
human cancer
4
cancer evaluated
4
lymphoblastic leukemia
4
tumor lung
4
large diverse
4
variety sporadic
4
lung adenocarcinoma
4
t-cell acute
4

References

(Supplied by CrossRef)

Aoki et al.
Nat Genet 2005

Bentires-Alj et al.
Nat Med 2006

Buday et al.
Oncogene 1995

Cichowski et al.
Cell 2001

Corbalan-Garcia et al.
Mol Cell Biol 1998

Digilio et al.
Am J Hum Genet 2002

Fong et al.
Cancer Res 2006

Fransen et al.
Carcinogenesis 2004

Gordon et al.
Genome Res 1998

Guha et al.
Oncogene 1997

Gutmann et al.
Neuropathol Appl Neurobiol 2000

Similar Publications